Haluzík, M <br/><br/>
[Pathophysiological background for incretin therapy: is it capable of more than we think?].  [electronic resource] 

 -  Vnitrni lekarstvi  Nov 2011 
 - 897-902 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article; Review 
<br/><br/><label>ISSN: </label>0042-773X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Glucagon-Like Peptide 1--agonists<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Incretins--pharmacology